What is Pideka Group Inc. (CIMVF)?

Pideka Group Inc. (CIMVF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of CIMVF?

The current price of CIMVF is $0.01. Prices are updated in real time on Stocks360.

What is CIMVF's price-to-earnings (PE) ratio?

CIMVF's trailing twelve-month PE ratio is -1.16, based on current price and earnings per share data available on Stocks360.

What is CIMVF's market capitalization?

CIMVF's market capitalization is $2,505,714.00, placing it in the small-cap tier.

Pideka Group Inc. (CIMVF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.01

Market Cap

$2.51M

PE (TTM)

-1.16

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.57

Day Range

$0.01 – $0.01

52-wk Range

$0.01 – $0.01

Avg Volume

N/A

Volume

22.00

Pideka Group Inc. (CIMVF) is a publicly traded company in the Healthcare sector. Latest price: $0.01. Market cap $2.51M. Trailing PE -1.16. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Pideka Group Inc.

Ikänik Farms, Inc. operates as a comprehensive, vertically integrated enterprise within the cannabis industry, handling everything from cultivation and processing to distribution and managing retail dispensaries. Its operations are established in both California and Colombia. The firm provides a diverse selection of cannabis-derived products, which includes pharmaceutical-grade cannabinoids, decarboxylated plant material, completed cannabidiol (CBD) items, and ready-to-use ingredient cannabis oil. These offerings are available for both scientific research and broader commercial markets. The company distributes its products through a range of distinct brands, namely Ikanik, Essentials, Ronen, and Rations. Its main corporate office is located in Toronto, Canada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-1.16×
P/S (TTM)	611.24×
P/B	-2.55×
PEG	0.02×
P/FCF (TTM)	-31.44×
EV / EBITDA	-26.77×
EV / Sales	594.38×
Earnings Yield	-86.32%
Free Cash Flow Yield	-3.18%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.44M
Revenue (TTM)	$4.10K
Net Income (TTM)	-$2.16M
Free Cash Flow (TTM)	-$79.71K
Net Debt	-$69.13K
Working Capital	-$41.38K
Gross Margin	13.07%
Operating Margin	-2220.58%
Net Margin	-2220.53%
Return on Equity	-1752.90%
Return on Invested Capital	1827.18%